Vitamin D in schizophrenia and depression_ a clinical review.pdf (228.09 kB)
Download file

Vitamin D in schizophrenia and depression: a clinical review

Download (228.09 kB)
journal contribution
posted on 17.12.2021, 09:57 authored by John LallyJohn Lally, Fiona P Gaughran

Evidence from preclinical and clinical studies supports a role for vitamin D deficiency in many mental disorders. In this review, we discuss the role of vitamin D in the aetiology and treatment of schizophrenia and depression and their physical health comorbidities. Although observational studies support a potential association between vitamin D and schizophrenia and depression, sufficient high-quality evidence from clinical trials does not yet exist to establish a place for vitamin D supplementation in optimising clinical response or promoting physical health. Completed randomised controlled trials are needed to provide insights into the efficacy and safety of vitamin D in the management of mental disorders.

History

Comments

The original article is available at https://www.cambridge.org/core/journals/bjpsych-advances

Published Citation

Lally J, Gaughran, F. Vitamin D in schizophrenia and depression: A clinical review. BJPsych Advances. 2019;25(4):240-248.

Publication Date

17 April 2019

Department/Unit

  • Psychiatry

Research Area

  • Neurological and Psychiatric Disorders

Publisher

Cambridge University Press

Version

  • Accepted Version (Postprint)